Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-28

FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for spironolactone filed by Amneal Pharmaceuticals LLC, a generic product. The approval confirms changes allowed under t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)